Logo image of 1AIXA.MI

AIXTRON SE (1AIXA.MI) Stock Fundamental Analysis

BIT:1AIXA - Euronext Milan - DE000A0WMPJ6 - Common Stock - Currency: EUR

11.715  -0.51 (-4.17%)

Fundamental Rating

5

Overall 1AIXA gets a fundamental rating of 5 out of 10. We evaluated 1AIXA against 54 industry peers in the Semiconductors & Semiconductor Equipment industry. 1AIXA has an excellent financial health rating, but there are some minor concerns on its profitability. 1AIXA is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year 1AIXA was profitable.
In the past year 1AIXA had a positive cash flow from operations.
In the past 5 years 1AIXA has always been profitable.
In multiple years 1AIXA reported negative operating cash flow during the last 5 years.
1AIXA.MI Yearly Net Income VS EBIT VS OCF VS FCF1AIXA.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M 150M

1.2 Ratios

With a Return On Assets value of 10.44%, 1AIXA perfoms like the industry average, outperforming 53.45% of the companies in the same industry.
The Return On Equity of 1AIXA (12.54%) is comparable to the rest of the industry.
With a Return On Invested Capital value of 13.23%, 1AIXA perfoms like the industry average, outperforming 58.62% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for 1AIXA is in line with the industry average of 16.29%.
Industry RankSector Rank
ROA 10.44%
ROE 12.54%
ROIC 13.23%
ROA(3y)11.89%
ROA(5y)10.9%
ROE(3y)15.45%
ROE(5y)13.91%
ROIC(3y)14.3%
ROIC(5y)12.62%
1AIXA.MI Yearly ROA, ROE, ROIC1AIXA.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

With a Profit Margin value of 16.79%, 1AIXA perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
1AIXA's Profit Margin has improved in the last couple of years.
1AIXA has a Operating Margin (20.73%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of 1AIXA has grown nicely.
1AIXA's Gross Margin of 41.45% is on the low side compared to the rest of the industry. 1AIXA is outperformed by 68.97% of its industry peers.
In the last couple of years the Gross Margin of 1AIXA has remained more or less at the same level.
Industry RankSector Rank
OM 20.73%
PM (TTM) 16.79%
GM 41.45%
OM growth 3Y-4.44%
OM growth 5Y8.24%
PM growth 3Y-9.03%
PM growth 5Y5.83%
GM growth 3Y-0.68%
GM growth 5Y-0.21%
1AIXA.MI Yearly Profit, Operating, Gross Margins1AIXA.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30 40

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 1AIXA is still creating some value.
1AIXA has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for 1AIXA has been increased compared to 5 years ago.
Compared to 1 year ago, 1AIXA has a worse debt to assets ratio.
1AIXA.MI Yearly Shares Outstanding1AIXA.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
1AIXA.MI Yearly Total Debt VS Total Assets1AIXA.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

1AIXA has an Altman-Z score of 6.77. This indicates that 1AIXA is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.77, 1AIXA is in the better half of the industry, outperforming 68.97% of the companies in the same industry.
1AIXA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 6.77
ROIC/WACC1.34
WACC9.9%
1AIXA.MI Yearly LT Debt VS Equity VS FCF1AIXA.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

1AIXA has a Current Ratio of 4.12. This indicates that 1AIXA is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 4.12, 1AIXA is in the better half of the industry, outperforming 77.59% of the companies in the same industry.
1AIXA has a Quick Ratio of 1.86. This is a normal value and indicates that 1AIXA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.86, 1AIXA is in the better half of the industry, outperforming 60.34% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.12
Quick Ratio 1.86
1AIXA.MI Yearly Current Assets VS Current Liabilites1AIXA.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

1AIXA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -27.13%.
1AIXA shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 26.52% yearly.
1AIXA shows a small growth in Revenue. In the last year, the Revenue has grown by 0.52%.
1AIXA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.52% yearly.
EPS 1Y (TTM)-27.13%
EPS 3Y3.43%
EPS 5Y26.52%
EPS Q2Q%-14.55%
Revenue 1Y (TTM)0.52%
Revenue growth 3Y13.86%
Revenue growth 5Y19.52%
Sales Q2Q%5.85%

3.2 Future

The Earnings Per Share is expected to decrease by -18.92% on average over the next years. This is quite bad
Based on estimates for the next years, 1AIXA will show a small growth in Revenue. The Revenue will grow by 5.23% on average per year.
EPS Next Y-0.67%
EPS Next 2Y5.26%
EPS Next 3Y31.83%
EPS Next 5Y-18.92%
Revenue Next Year-9.74%
Revenue Next 2Y-0.56%
Revenue Next 3Y3.57%
Revenue Next 5Y5.23%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1AIXA.MI Yearly Revenue VS Estimates1AIXA.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M
1AIXA.MI Yearly EPS VS Estimates1AIXA.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 1.5 2

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 12.46, the valuation of 1AIXA can be described as correct.
Based on the Price/Earnings ratio, 1AIXA is valued a bit cheaper than the industry average as 79.31% of the companies are valued more expensively.
1AIXA's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.41.
A Price/Forward Earnings ratio of 12.55 indicates a correct valuation of 1AIXA.
1AIXA's Price/Forward Earnings ratio is rather cheap when compared to the industry. 1AIXA is cheaper than 82.76% of the companies in the same industry.
1AIXA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.19.
Industry RankSector Rank
PE 12.46
Fwd PE 12.55
1AIXA.MI Price Earnings VS Forward Price Earnings1AIXA.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1AIXA indicates a somewhat cheap valuation: 1AIXA is cheaper than 65.52% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.69
1AIXA.MI Per share data1AIXA.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

1AIXA's earnings are expected to grow with 31.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)0.47
EPS Next 2Y5.26%
EPS Next 3Y31.83%

4

5. Dividend

5.1 Amount

1AIXA has a Yearly Dividend Yield of 3.48%.
Compared to an average industry Dividend Yield of 1.19, 1AIXA pays a better dividend. On top of this 1AIXA pays more dividend than 94.83% of the companies listed in the same industry.
1AIXA's Dividend Yield is a higher than the S&P500 average which is at 2.35.
Industry RankSector Rank
Dividend Yield 3.48%

5.2 History

Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

1AIXA pays out 42.37% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP42.37%
EPS Next 2Y5.26%
EPS Next 3Y31.83%
1AIXA.MI Yearly Income VS Free CF VS Dividend1AIXA.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M
1AIXA.MI Dividend Payout.1AIXA.MI Dividend Payout, showing the Payout Ratio.1AIXA.MI Dividend Payout.PayoutRetained Earnings

AIXTRON SE

BIT:1AIXA (3/3/2025, 7:00:00 PM)

11.715

-0.51 (-4.17%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-27 2025-02-27/bmo
Earnings (Next)04-30 2025-04-30
Inst Owners60.51%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.33B
Analysts75.2
Price Target16.32 (39.31%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.48%
Yearly Dividend0.4
Dividend Growth(5Y)N/A
DP42.37%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-15.14%
Min EPS beat(2)-17.44%
Max EPS beat(2)-12.83%
EPS beat(4)0
Avg EPS beat(4)-16.35%
Min EPS beat(4)-18.57%
Max EPS beat(4)-12.83%
EPS beat(8)2
Avg EPS beat(8)-13.52%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.27%
Min Revenue beat(2)-5.69%
Max Revenue beat(2)3.14%
Revenue beat(4)2
Avg Revenue beat(4)-0.15%
Min Revenue beat(4)-5.69%
Max Revenue beat(4)3.46%
Revenue beat(8)3
Avg Revenue beat(8)-3.45%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-33.11%
PT rev (3m)-33.11%
EPS NQ rev (1m)-51.64%
EPS NQ rev (3m)-51.64%
EPS NY rev (1m)-29.87%
EPS NY rev (3m)-29.87%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-16.96%
Revenue NY rev (3m)-16.96%
Valuation
Industry RankSector Rank
PE 12.46
Fwd PE 12.55
P/S 2.1
P/FCF N/A
P/OCF 50.69
P/B 1.57
P/tB 1.73
EV/EBITDA 8.69
EPS(TTM)0.94
EY8.02%
EPS(NY)0.93
Fwd EY7.97%
FCF(TTM)-0.64
FCFYN/A
OCF(TTM)0.23
OCFY1.97%
SpS5.58
BVpS7.47
TBVpS6.76
PEG (NY)N/A
PEG (5Y)0.47
Profitability
Industry RankSector Rank
ROA 10.44%
ROE 12.54%
ROCE 15.34%
ROIC 13.23%
ROICexc 14.31%
ROICexgc 15.94%
OM 20.73%
PM (TTM) 16.79%
GM 41.45%
FCFM N/A
ROA(3y)11.89%
ROA(5y)10.9%
ROE(3y)15.45%
ROE(5y)13.91%
ROIC(3y)14.3%
ROIC(5y)12.62%
ROICexc(3y)20.39%
ROICexc(5y)21.53%
ROICexgc(3y)24.32%
ROICexgc(5y)27.84%
ROCE(3y)16.59%
ROCE(5y)14.64%
ROICexcg growth 3Y-31.97%
ROICexcg growth 5Y-13.38%
ROICexc growth 3Y-26.07%
ROICexc growth 5Y-4.84%
OM growth 3Y-4.44%
OM growth 5Y8.24%
PM growth 3Y-9.03%
PM growth 5Y5.83%
GM growth 3Y-0.68%
GM growth 5Y-0.21%
F-Score5
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 693.74%
Cap/Sales 15.59%
Interest Coverage 497.1
Cash Conversion 18.03%
Profit Quality N/A
Current Ratio 4.12
Quick Ratio 1.86
Altman-Z 6.77
F-Score5
WACC9.9%
ROIC/WACC1.34
Cap/Depr(3y)522.62%
Cap/Depr(5y)368.53%
Cap/Sales(3y)10.65%
Cap/Sales(5y)7.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.13%
EPS 3Y3.43%
EPS 5Y26.52%
EPS Q2Q%-14.55%
EPS Next Y-0.67%
EPS Next 2Y5.26%
EPS Next 3Y31.83%
EPS Next 5Y-18.92%
Revenue 1Y (TTM)0.52%
Revenue growth 3Y13.86%
Revenue growth 5Y19.52%
Sales Q2Q%5.85%
Revenue Next Year-9.74%
Revenue Next 2Y-0.56%
Revenue Next 3Y3.57%
Revenue Next 5Y5.23%
EBIT growth 1Y-16.29%
EBIT growth 3Y8.8%
EBIT growth 5Y29.37%
EBIT Next Year16.17%
EBIT Next 3Y24.44%
EBIT Next 5Y20.42%
FCF growth 1Y34.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y155.46%
OCF growth 3Y-26.62%
OCF growth 5Y-9.34%